Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Smith, T. Kidd, K. Ramsay, S. Tai, S. Bell (Brisbane, Australia). Scedosporium species (Sspp) in patients with cystic fibrosis (CF): Implications for clinical practice. Eur Respir J 2010; 36: Suppl. 54, 3498

Member's Comments

No comment yet.

Related content which might interest you: Macrolides in cystic fibrosis (CF); clinical experience Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004 Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Patient centred research: a model for involving cystic fibrosis (CF) patients in research planning Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Scedosporium induced deterioration and treatment in juvenile cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Evolution of the infectious disease in cystic fibrosis (CF) Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005 Achromobacter xylosoxidans strains with shared genotype among patients attending a cystic fibrosis (CF) rehabilitation centre Source: Eur Respir J 2005; 26: Suppl. 49, 596s Year: 2005 The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015